Ionis Pharmaceuticals, Inc.'s revenue has grown 12% a year over three years, and grown 4.9% a year over five. Revenue growth, 3-year annual rate: +12% (Biotechnology median +21%). Revenue growth, 5-year rate: +4.9%, growth has picked up over the last three years. Years of annual history on file: 18, FY2008 to FY2025, as filed.

IONSIonis Pharmaceuticals, Inc.

Healthcare

$42.92-41% 1Y

$42.92

$42.3652 weeks$86.50

Is it growing?

Watch

Growth is fading: revenue shrinking (−7% year on year) and operating margin narrowing (−13.2 points).

2 to watch, 1 without data

Revenue trend−7% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +5% a year.

Margin direction−13.2 points operating

Trailing-twelve-month operating margin, -73.4% now against -60.2% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is IONS growing?

Ionis Pharmaceuticals, Inc.'s revenue has grown 12% a year over three years, and grown 4.9% a year over five.

+12%

Revenue growth, 3-year annual rate · Biotechnology median +21% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +4.9%
Revenue growth, 5-year rate · +12% over three · growth has picked up over the last three years
Years of annual history on file: 18
Years of annual history on file · FY2008 to FY2025, as filed

Details›